Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Inebilizumab in IgG4-Related Disease: Protocol for a Randomized Controlled Trial

Published:2023-10-04 Issue:6 Volume:10 Page:1795-1808
ISSN:2198-6576
Container-title:Rheumatology and Therapy
language:en
Short-container-title:Rheumatol Ther

Author:

Perugino Cory,Culver Emma L.,Khosroshahi Arezou^ORCID,Zhang Wen,Della-Torre Emanuel,Okazaki Kazuichi,Tanaka Yoshiya^ORCID,Löhr Matthias,Schleinitz Nicolas,Falloon Judith,She Dewei,Cimbora Daniel,Stone John H.^ORCID

Funder

Horizon Therapeutics

Publisher

Springer Science and Business Media LLC

Subject

Immunology and Allergy,Rheumatology

Link

https://link.springer.com/content/pdf/10.1007/s40744-023-00593-7.pdf

Reference48 articles.

1. Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366(6):539–51.

2. Perugino CA, Stone JH. IgG4-related disease: an update on pathophysiology and implications for clinical care. Nat Rev Rheumatol. 2020;16(12):702–14.

3. Wallace ZS, Naden RP, Chari S, et al. The 2019 American College of Rheumatology/European League against rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020;72(1):7–19.

4. Löhr JM, Vujasinovic M, Rosendahl J, Stone JH, Beuers U. IgG4-related diseases of the digestive tract. Nat Rev Gastroenterol Hepatol. 2022;19(3):185–97.

5. Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol. 2012;29(4):191–6.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pancreas 2000. My journey with the central organ;Pancreatology;2024-08

2. Theranostic nanoparticles for detection and treatment of pancreatic cancer;WIREs Nanomedicine and Nanobiotechnology;2024-07

3. Pathogenic roles of follicular helper T cells in IgG4-related disease and implications for potential therapy;Frontiers in Immunology;2024-06-07

4. Autoimmunpankreatitis und IgG4-assoziierte Erkrankungen;Gastroenterologie up2date;2024-06

5. B cell depletion after treatment with rituximab predicts relapse of IgG4-related disease;Rheumatology;2024-05-23